Medical Bionics Market by Product (Heart [Pacemaker, VAD, Artificial Heart Valves, Total Artificial Heart], Neural/Brain [SCSs, DBSs, TENS, SNSs, VNSs], Ear [Cochlear Implants, Bone Anchored Hearing Systems, Auditory Brainstem Implants], Orthopedic [Lower Limb, Upper Limb, Exoskeleton], Vision/Eye), by Fixation Type (Implantable, Non-Implantable), by Geography (U.S., Canada, Germany, U.K., France, Italy, Spain, Japan, China, India, Brazil, Mexico) – Global Market Size, Share, Development, Growth, and Demand Forecast, 2013–2023

Chapter 1. Research Background

1.1 Research Objectives

1.2 Market Definition

1.3 Research Scope

1.3.1 Market Segmentation by Product

1.3.2 Market Segmentation by Fixation Type

1.3.3 Market Segmentation by Geography

1.3.4 Analysis Period

1.3.5 Market Data Reporting Unit

1.3.5.1 Value

1.4 Key Stakeholders

Chapter 2. Research Methodology

2.1 Secondary Research

2.2 Primary Research

2.2.1 Breakdown of Primary Research Respondents

2.2.1.1 By region

2.2.1.2 By industry participant

2.2.1.3 By company type

2.3 Market Size Estimation

2.4 Data Triangulation

2.5 Assumptions for the Study

Chapter 3. Executive Summary

3.1 Voice of Industry Experts/KOLs

Chapter 4. Introduction

4.1 Definition of Market Segments

4.1.1 By Product

4.1.1.1 Heart bionics

4.1.1.1.1 Pacemaker

4.1.1.1.1.1 Implantable

4.1.1.1.1.2 External

4.1.1.1.2 Ventricular assist device (VAD)

4.1.1.1.2.1 Left VAD

4.1.1.1.2.2 Right VAD

4.1.1.1.3 Artificial heart valves

4.1.1.1.3.1 Mechanical

4.1.1.1.3.2 Tissue

4.1.1.1.4 Total artificial heart

4.1.1.2 Neural/brain bionics

4.1.1.2.1 Spinal cord stimulators (SCSs)

4.1.1.2.2 Deep brain stimulators (DBSs)

4.1.1.2.3 Transcutaneous electrical nerve stimulation (TENS)

4.1.1.2.4 Sacral nerve stimulators (SNSs)

4.1.1.2.5 Vagus nerve stimulators (VNSs)

4.1.1.2.6 Others

4.1.1.3 Ear bionics

4.1.1.3.1 Cochlear implants

4.1.1.3.2 Bone anchored hearing systems

4.1.1.3.3 Auditory brainstem implants

4.1.1.4 Orthopedic bionics

4.1.1.4.1 Upper limb

4.1.1.4.2 Lower limb

4.1.1.4.2.1 Bionic knee

4.1.1.4.2.2 Bionic foot

4.1.1.4.3 Exoskeleton

4.1.1.5 Vision/eye bionics

4.1.1.6 Others

4.1.2 By Fixation Type

4.1.2.1 Implantable

4.1.2.2 Non-implantable

4.2 Market Dynamics

4.2.1 Trends

4.2.1.1 Technologically advanced medical bionics

4.2.1.2 Increasing government focus on funding R&D initiatives

4.2.2 Drivers

4.2.2.1 Increasing pool of geriatric population and associated organ failures

4.2.2.2 Technological advancements

4.2.2.3 Increasing accidents and injuries leading to amputations

4.2.2.4 Rising number of people opting for organ transplants

4.2.2.5 Rising prevalence of chronic diseases

4.2.2.6 Impact analysis of drivers on market forecast

4.2.3 Restraints

4.2.3.1 High cost of devices and associated procedures

4.2.3.2 Uncertain reimbursement scenarios in different regions

4.2.3.3 Dearth of surgical experience

4.2.3.4 Stringent approval process

4.2.3.5 Fear of device failure or malfunction

4.2.3.6 Criticism associated with artificial organ transplant

4.2.3.7 Impact analysis of restraints on market forecast

4.2.4 Opportunities

4.2.4.1 Improving income levels in emerging economies

4.2.4.2 Increasing awareness levels about medical bionics

4.3 Porter’s Five Forces Analysis

4.3.1 Bargaining Power of Buyers

4.3.2 Bargaining Power of Suppliers

4.3.3 Intensity of Rivalry

4.3.4 Threat of New Entrants

4.3.5 Threat of Substitutes

Chapter 5. Global Market Size and Forecast

5.1 By Product

5.1.1 Heart Bionics Market by Type

5.1.1.1 Pacemaker market by type

5.1.1.2 VAD market by type

5.1.1.3 Artificial heart valves market by type

5.1.2 Ear Bionics Market by Type

5.1.3 Orthopedic Bionics Market by Type

5.1.3.1 Lower limb bionics market by type

5.1.4 Neural/Brain Bionics Market by Type

5.2 By Fixation Type

5.3 By Region

Chapter 6. North America Market Size and Forecast

6.1 By Product

6.1.1 Heart Bionics Market by Type

6.1.1.1 Pacemaker market by type

6.1.1.2 VAD market by type

6.1.1.3 Artificial heart valves market by type

6.1.2 Ear Bionics Market by Type

6.1.3 Orthopedic Bionics Market by Type

6.1.3.1 Lower limb bionics market by type

6.1.4 Neural/Brain Bionics Market by Type

6.2 By Fixation Type

6.3 By Country

Chapter 7. Europe Market Size and Forecast

7.1 By Product

7.1.1 Heart Bionics Market by Type

7.1.1.1 Pacemaker market by type

7.1.1.2 VAD market by type

7.1.1.3 Artificial heart valves market by type

7.1.2 Ear Bionics Market by Type

7.1.3 Orthopedic Bionics Market by Type

7.1.3.1 Lower limb bionics market by type

7.1.4 Neural/Brain Bionics Market by Type

7.2 By Fixation Type

7.3 By Country

Chapter 8. APAC Market Size and Forecast

8.1 By Product

8.1.1 Heart Bionics Market by Type

8.1.1.1 Pacemaker market by type

8.1.1.2 VAD market by type

8.1.1.3 Artificial heart valves market by type

8.1.2 Ear Bionics Market by Type

8.1.3 Orthopedic Bionics Market by Type

8.1.3.1 Lower limb bionics market by type

8.1.4 Neural/Brain Bionics Market by Type

8.2 By Fixation Type

8.3 By Country

Chapter 9. RoW Market Size and Forecast

9.1 By Product

9.1.1 Heart Bionics Market by Type

9.1.1.1 Pacemaker market by type

9.1.1.2 VAD market by type

9.1.1.3 Artificial heart valves market by type

9.1.2 Ear Bionics Market by Type

9.1.3 Orthopedic Bionics Market by Type

9.1.3.1 Lower limb bionics market by type

9.1.4 Neural/Brain Bionics Market by Type

9.2 By Fixation Type

9.3 By Country

Chapter 10. Competitive Landscape

10.1 Product Benchmarking of Key Players

10.2 Global Strategic Developments of Key Players

10.2.1 Product Launches

10.2.2 Mergers and Acquisitions

10.2.3 Partnerships

10.2.4 Other Developments

Chapter 11. Company Profiles

11.1 ÖSSUR hf

11.1.1 Business Overview

11.1.2 Product and Service Offerings

11.1.3 Key Financial Summary

11.1.4 Strategic Growth Plans

11.2 Cochlear Ltd.

11.2.1 Business Overview

11.2.2 Product and Service Offerings

11.2.3 Key Financial Summary

11.2.4 Strategic Growth Plans

11.3 Medtronic plc

11.3.1 Business Overview

11.3.2 Product and Service Offerings

11.3.3 Key Financial Summary

11.3.4 Strategic Growth Plans

11.4 Edwards Lifesciences Corporation

11.4.1 Business Overview

11.4.2 Product and Service Offerings

11.4.3 Key Financial Summary

11.4.4 Strategic Growth Plans

11.5 Boston Scientific Corporation

11.5.1 Business Overview

11.5.2 Product and Service Offerings

11.5.3 Key Financial Summary

11.5.4 Strategic Growth Plans

11.6 Ekso Bionics Holdings Inc.

11.6.1 Business Overview

11.6.2 Product and Service Offerings

11.6.3 Key Financial Summary

11.6.4 Strategic Growth Plans

11.7 LifeNet Health

11.7.1 Business Overview

11.7.2 Product and Service Offerings

11.7.3 Strategic Growth Plan

11.8 Retina Implant AG

11.8.1 Business Overview

11.8.2 Product and Service Offerings

11.9 Orthofix International N.V.

11.9.1 Business Overview

11.9.2 Product and Service Offerings

11.9.3 Key Financial Summary

11.9.4 Strategic Growth Plans

11.1 Otto Bock Holding GmbH & Co. KG.

11.10.1 Business Overview

11.10.2 Product and Service Offerings

Chapter 12. Appendix

12.1 Abbreviations

12.2 Sources and References

12.3 Related Reports

 

List of Tables

 

TABLE 1 ANALYSIS PERIOD OF THE STUDY

TABLE 2 DRIVERS FOR THE MARKET: IMPACT ANALYSIS

TABLE 3 RESTRAINTS FOR THE MARKET: IMPACT ANALYSIS

TABLE 4 GLOBAL MEDICAL BIONICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 5 GLOBAL MEDICAL BIONICS MARKET, BY PRODUCT, $M (2025–2030)

TABLE 6 GLOBAL HEART BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 7 GLOBAL HEART BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 8 GLOBAL PACEMAKER MARKET, BY TYPE, $M (2019–2024)

TABLE 9 GLOBAL PACEMAKER MARKET, BY TYPE, $M (2025–2030)

TABLE 10 GLOBAL VAD MARKET, BY TYPE, $M (2019–2024)

TABLE 11 GLOBAL VAD MARKET, BY TYPE, $M (2025–2030)

TABLE 12 GLOBAL ARTIFICIAL HEART VALVES MARKET, BY TYPE, $M (2019–2024)

TABLE 13 GLOBAL ARTIFICIAL HEART VALVES MARKET, BY TYPE, $M (2025–2030)

TABLE 14 GLOBAL EAR BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 15 GLOBAL EAR BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 16 GLOBAL ORTHOPEDIC BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 17 GLOBAL ORTHOPEDIC BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 18 GLOBAL LOWER LIMB BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 19 GLOBAL LOWER LIMB BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 20 GLOBAL NEURAL/BRAIN BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 21 GLOBAL NEURAL/BRAIN BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 22 GLOBAL MEDICAL BIONICS MARKET, BY FIXATION TYPE, $M (2019–2024)

TABLE 23 GLOBAL MEDICAL BIONICS MARKET, BY FIXATION TYPE, $M (2025–2030)

TABLE 24 GLOBAL MEDICAL BIONICS MARKET, BY REGION, $M (2019–2024)

TABLE 25 GLOBAL MEDICAL BIONICS MARKET, BY REGION, $M (2025–2030)

TABLE 26 NORTH AMERICA MEDICAL BIONICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 27 NORTH AMERICA MEDICAL BIONICS MARKET, BY PRODUCT, $M (2025–2030)

TABLE 28 NORTH AMERICA HEART BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 29 NORTH AMERICA HEART BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 30 NORTH AMERICA PACEMAKER MARKET, BY TYPE, $M (2019–2024)

TABLE 31 NORTH AMERICA PACEMAKER MARKET, BY TYPE, $M (2025–2030)

TABLE 32 NORTH AMERICA VAD MARKET, BY TYPE, $M (2019–2024)

TABLE 33 NORTH AMERICA VAD MARKET, BY TYPE, $M (2025–2030)

TABLE 34 NORTH AMERICA ARTIFICIAL HEART VALVES MARKET, BY TYPE, $M (2019–2024)

TABLE 35 NORTH AMERICA ARTIFICIAL HEART VALVES MARKET, BY TYPE, $M (2025–2030)

TABLE 36 NORTH AMERICA EAR BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 37 NORTH AMERICA EAR BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 38 NORTH AMERICA ORTHOPEDIC BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 39 NORTH AMERICA ORTHOPEDIC BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 40 NORTH AMERICA LOWER LIMB BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 41 NORTH AMERICA LOWER LIMB BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 42 NORTH AMERICA NEURAL/BRAIN BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 43 NORTH AMERICA NEURAL/BRAIN BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 44 NORTH AMERICA MEDICAL BIONICS MARKET, BY FIXATION TYPE, $M (2019–2024)

TABLE 45 NORTH AMERICA MEDICAL BIONICS MARKET, BY FIXATION TYPE, $M (2025–2030)

TABLE 46 NORTH AMERICA MEDICAL BIONICS MARKET, BY COUNTRY, $M (2019–2024)

TABLE 47 NORTH AMERICA MEDICAL BIONICS MARKET, BY COUNTRY, $M (2025–2030)

TABLE 48 EUROPE MEDICAL BIONICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 49 EUROPE MEDICAL BIONICS MARKET, BY PRODUCT, $M (2025–2030)

TABLE 50 EUROPE HEART BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 51 EUROPE HEART BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 52 EUROPE PACEMAKER MARKET, BY TYPE, $M (2019–2024)

TABLE 53 EUROPE PACEMAKER MARKET, BY TYPE, $M (2025–2030)

TABLE 54 EUROPE VAD MARKET, BY TYPE, $M (2019–2024)

TABLE 55 EUROPE VAD MARKET, BY TYPE, $M (2025–2030)

TABLE 56 EUROPE ARTIFICIAL HEART VALVES MARKET, BY TYPE, $M (2019–2024)

TABLE 57 EUROPE ARTIFICIAL HEART VALVES MARKET, BY TYPE, $M (2025–2030)

TABLE 58 EUROPE EAR BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 59 EUROPE EAR BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 60 EUROPE ORTHOPEDIC BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 61 EUROPE ORTHOPEDIC BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 62 EUROPE LOWER LIMB BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 63 EUROPE LOWER LIMB BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 64 EUROPE NEURAL/BRAIN BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 65 EUROPE NEURAL/BRAIN BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 66 EUROPE MEDICAL BIONICS MARKET, BY FIXATION TYPE, $M (2019–2024)

TABLE 67 EUROPE MEDICAL BIONICS MARKET, BY FIXATION TYPE, $M (2025–2030)

TABLE 68 EUROPE MEDICAL BIONICS MARKET, BY COUNTRY, $M (2019–2024)

TABLE 69 EUROPE MEDICAL BIONICS MARKET, BY COUNTRY, $M (2025–2030)

TABLE 70 APAC MEDICAL BIONICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 71 APAC MEDICAL BIONICS MARKET, BY PRODUCT, $M (2025–2030)

TABLE 72 APAC HEART BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 73 APAC HEART BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 74 APAC PACEMAKER MARKET, BY TYPE, $M (2019–2024)

TABLE 75 APAC PACEMAKER MARKET, BY TYPE, $M (2025–2030)

TABLE 76 APAC VAD MARKET, BY TYPE, $M (2019–2024)

TABLE 77 APAC VAD MARKET, BY TYPE, $M (2025–2030)

TABLE 78 APAC ARTIFICIAL HEART VALVES MARKET, BY TYPE, $M (2019–2024)

TABLE 79 APAC ARTIFICIAL HEART VALVES MARKET, BY TYPE, $M (2025–2030)

TABLE 80 APAC EAR BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 81 APAC EAR BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 82 APAC ORTHOPEDIC BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 83 APAC ORTHOPEDIC BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 84 APAC LOWER LIMB BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 85 APAC LOWER LIMB BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 86 APAC NEURAL/BRAIN BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 87 APAC NEURAL/BRAIN BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 88 APAC MEDICAL BIONICS MARKET, BY FIXATION TYPE, $M (2019–2024)

TABLE 89 APAC MEDICAL BIONICS MARKET, BY FIXATION TYPE, $M (2025–2030)

TABLE 90 APAC MEDICAL BIONICS MARKET, BY COUNTRY, $M (2019–2024)

TABLE 91 APAC MEDICAL BIONICS MARKET, BY COUNTRY, $M (2025–2030)

TABLE 92 COST OF MEDICAL TREATMENTS IN MEXICO COMPARED TO THE U.S. HOSPITALS

TABLE 93 ROW MEDICAL BIONICS MARKET, BY PRODUCT, $M (2019–2024)

TABLE 94 ROW MEDICAL BIONICS MARKET, BY PRODUCT, $M (2025–2030)

TABLE 95 ROW HEART BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 96 ROW HEART BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 97 ROW PACEMAKER MARKET, BY TYPE, $M (2019–2024)

TABLE 98 ROW PACEMAKER MARKET, BY TYPE, $M (2025–2030)

TABLE 99 ROW VAD MARKET, BY TYPE, $M (2019–2024)

TABLE 100 ROW VAD MARKET, BY TYPE, $M (2025–2030)

TABLE 101 ROW ARTIFICIAL HEART VALVES MARKET, BY TYPE, $M (2019–2024)

TABLE 102 ROW ARTIFICIAL HEART VALVES MARKET, BY TYPE, $M (2025–2030)

TABLE 103 ROW EAR BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 104 ROW EAR BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 105 ROW ORTHOPEDIC BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 106 ROW ORTHOPEDIC BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 107 ROW LOWER LIMB BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 108 ROW LOWER LIMB BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 109 ROW NEURAL/BRAIN BIONICS MARKET, BY TYPE, $M (2019–2024)

TABLE 110 ROW NEURAL/BRAIN BIONICS MARKET, BY TYPE, $M (2025–2030)

TABLE 111 ROW MEDICAL BIONICS MARKET, BY FIXATION TYPE, $M (2019–2024)

TABLE 112 ROW MEDICAL BIONICS MARKET, BY FIXATION TYPE, $M (2025–2030)

TABLE 113 ROW MEDICAL BIONICS MARKET, BY COUNTRY, $M (2019–2024)

TABLE 114 ROW MEDICAL BIONICS MARKET, BY COUNTRY, $M (2025–2030)

TABLE 115 ÖSSUR HF – AT A GLANCE

TABLE 116 ÖSSUR HF – KEY FINANCIAL SUMMARY

TABLE 117 COCHLEAR LTD. – AT A GLANCE

TABLE 118 COCHLEAR LTD. – KEY FINANCIAL SUMMARY

TABLE 119 MEDTRONIC PLC – AT A GLANCE

TABLE 120 MEDTRONIC PLC - KEY FINANCIAL SUMMARY

TABLE 121 EDWARDS LIFESCIENCES CORPORATION – AT A GLANCE

TABLE 122 EDWARDS LIFESCIENCES CORPORATION – KEY FINANCIAL SUMMARY

TABLE 123 BOSTON SCIENTIFIC CORPORATION – AT A GLANCE

TABLE 124 BOSTON SCIENTIFIC COPORATION – KEY FINANCIAL SUMMARY

 

List of Figures

 

FIG 1 RESEARCH SCOPE

FIG 2 RESEARCH METHODOLOGY

FIG 3 REGIONAL SPLIT OF PRIMARY AND SECONDARY RESEARCH

FIG 4 BREAKDOWN OF PRIMARY RESEARCH BY REGION

FIG 5 BREAKDOWN OF PRIMARY RESEARCH BY INDUSTRY PARTICIPANT

FIG 6 BREAKDOWN OF PRIMARY RESEARCH BY COMPANY TYPE

FIG 7 DATA TRIANGULATION APPROACH

FIG 8 GLOBAL MEDICAL BIONICS MARKET SUMMARY

FIG 9 OPINION OF INDUSTRY EXPERTS/KOLS

FIG 10 PORTER’S FIVE FORCES ANALYSIS

FIG 11 GLOBAL MEDICAL BIONICS MARKET SNAPSHOT, BY PRODUCT (2023)

FIG 12 GLOBAL MEDICAL BIONICS MARKET, BY PRODUCT, $M (2019–2030)

FIG 13 GLOBAL HEART BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 14 GLOBAL PACEMAKER MARKET, BY TYPE, $M (2019–2030)

FIG 15 GLOBAL VAD MARKET, BY TYPE, $M (2019–2030)

FIG 16 GLOBAL ARTIFICIAL HEART VALVES MARKET, BY TYPE, $M (2019–2030)

FIG 17 GLOBAL EAR BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 18 GLOBAL ORTHOPEDIC BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 19 GLOBAL LOWER LIMB BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 20 GLOBAL NEURAL/BRAIN BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 21 GLOBAL MEDICAL BIONICS MARKET, BY FIXATION TYPE, $M (2019–2030)

FIG 22 WORLDWIDE MAJOR MARKETS FOR MEDICAL BIONICS

FIG 23 NORTH AMERICA MEDICAL BIONICS MARKET SNAPSHOT

FIG 24 NORTH AMERICA MEDICAL BIONICS MARKET, BY PRODUCT, $M (2019–2030)

FIG 25 NORTH AMERICA HEART BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 26 NORTH AMERICA PACEMAKER MARKET, BY TYPE, $M (2019–2030)

FIG 27 NORTH AMERICA VAD MARKET, BY TYPE, $M (2019–2030)

FIG 28 NORTH AMERICA ARTIFICIAL HEART VALVES MARKET, BY TYPE, $M (2019–2030)

FIG 29 NORTH AMERICA EAR BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 30 NORTH AMERICA ORTHOPEDIC BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 31 NORTH AMERICA LOWER LIMB BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 32 NORTH AMERICA NEURAL/BRAIN BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 33 NORTH AMERICA MEDICAL BIONICS MARKET, BY FIXATION TYPE, $M (2019–2030)

FIG 34 NORTH AMERICA MEDICAL BIONICS MARKET, BY COUNTRY, $M (2019–2030)

FIG 35 EUROPE MEDICAL BIONICS MARKET SNAPSHOT

FIG 36 EUROPE MEDICAL BIONICS MARKET, BY PRODUCT, $M (2019–2030)

FIG 37 EUROPE HEART BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 38 EUROPE PACEMAKER MARKET, BY TYPE, $M (2019–2030)

FIG 39 EUROPE VAD MARKET, BY TYPE, $M (2019–2030)

FIG 40 EUROPE ARTIFICIAL HEART VALVES MARKET, BY TYPE, $M (2019–2030)

FIG 41 EUROPE EAR BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 42 EUROPE ORTHOPEDIC BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 43 EUROPE LOWER LIMB BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 44 EUROPE NEURAL/BRAIN BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 45 EUROPE MEDICAL BIONICS MARKET, BY FIXATION TYPE, $M (2019–2030)

FIG 46 EUROPE MEDICAL BIONICS MARKET, BY COUNTRY, $M (2019–2030)

FIG 47 APAC MEDICAL BIONICS MARKET SNAPSHOT

FIG 48 APAC MEDICAL BIONICS MARKET, BY PRODUCT, $M (2019–2030)

FIG 49 APAC HEART BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 50 APAC PACEMAKER MARKET, BY TYPE, $M (2019–2030)

FIG 51 APAC VAD MARKET, BY TYPE, $M (2019–2030)

FIG 52 APAC ARTIFICIAL HEART VALVES MARKET, BY TYPE, $M (2019–2030)

FIG 53 APAC EAR BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 54 APAC ORTHOPEDIC BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 55 APAC LOWER LIMB BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 56 APAC NEURAL/BRAIN BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 57 APAC MEDICAL BIONICS MARKET, BY FIXATION TYPE, $M (2019–2030)

FIG 58 APAC MEDICAL BIONICS MARKET, BY COUNTRY, $M (2019–2030)

FIG 59 ROW MEDICAL BIONICS MARKET SNAPSHOT

FIG 60 ROW MEDICAL BIONICS MARKET, BY PRODUCT, $M (2019–2030)

FIG 61 ROW HEART BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 62 ROW PACEMAKER MARKET, BY TYPE, $M (2019–2030)

FIG 63 ROW VAD MARKET, BY TYPE, $M (2019–2030)

FIG 64 ROW ARTIFICIAL HEART VALVES MARKET, BY TYPE, $M (2019–2030)

FIG 65 ROW EAR BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 66 ROW ORTHOPEDIC BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 67 ROW LOWER LIMB BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 68 ROW NEURAL/BRAIN BIONICS MARKET, BY TYPE, $M (2019–2030)

FIG 69 ROW MEDICAL BIONICS MARKET, BY FIXATION TYPE, $M (2019–2030)

FIG 70 ROW MEDICAL BIONICS MARKET, BY COUNTRY, $M (2019–2030)

FIG 71 PRODUCT BENCHMARKING OF KEY PLAYERS

FIG 72 GLOBAL STRATEGIC DEVELOPMENT OF KEY PLAYERS

FIG 73 ÖSSUR HF – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 74 COCHLEAR LTD. – REVENUE SPLIT BY PRODUCT LINE AND GEOGRAPHY (2023)

FIG 75 MEDTRONIC PLC – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 76 EDWARDS LIFESCIENCES CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 77 BOSTON SCIENTIFIC CORPORATION – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 78 EKSO BIONICS HOLDINGS INC. – AT A GLANCE

FIG 79 EKSO BIONICS HOLDINGS INC. – KEY FINANCIAL SUMMARY

FIG 80 EKSO BIONICS HOLDINGS INC. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 81 LIFENET HEALTH – AT A GLANCE

FIG 82 RETINA IMPLANT AG – AT A GLANCE

FIG 83 ORTHOFIX INTERNATIONAL N.V. – AT A GLANCE

FIG 84 ORTHOFIX INTERNATONAL N.V. – KEY FINANCIAL SUMMARY

FIG 85 ORTHOFIX INTERNATIONAL N.V. – REVENUE SPLIT BY SEGMENT AND GEOGRAPHY (2023)

FIG 86 OTTO BOCK HOLDING GMBH & CO. KG. – AT A GLANCE